Vimarsana
Biggest News Aggregation in the World

Quaker Str News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quaker Str. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quaker Str Today - Breaking & Trending Today

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil - Vimarsana News

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

A new review paper was published in Oncotarget's Volume 14 on December 12, 2023, entitled, “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability.”Credit: 2023 Xavier et al. A new review paper was published in

Osteopontin induces mitochondrial biogenesis - Vimarsana News

Osteopontin induces mitochondrial biogenesis

<p>On December 1, 2023, a new research paper was published in <a href="https://www.oncotarget.com/"><em><u>Oncotarget</u></em></a><em>,&nbsp;</em>entitled, &ldquo;<a href="https://doi.org/10.18632/oncotarget.28540"><u>Osteopontin induces mitochondrial biogenesis in deadherent cancer cells</u></a>.&rdquo;</p>

DPDT anticancer activity in human colon cance - Vimarsana News

DPDT anticancer activity in human colon cance

On June 21, 2023, a new research paper was published in Oncotarget, entitled, “Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells.”

ACSL4: Biomarker, mediator and target in quad - Vimarsana News

ACSL4: Biomarker, mediator and target in quad

On June 12, 2023, a new review was published in Oncotarget, entitled, “ACSL4: biomarker, mediator and target in quadruple negative breast cancer.”

Targeting the Src N-Terminal regulatory eleme - Vimarsana News

Targeting the Src N-Terminal regulatory eleme

On May 19, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting the Src N-terminal regulatory element in cancer.”